US Patent Issued to BIONTECH, TRON-TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE on Jan. 13 for "IL2 agonists" (German Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,640, issued on Jan. 13, was assigned to BIONTECH SE (Mainz, Germany) and TRON-TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH (Mainz, Germany).

"IL2 agonists" was invented by Ugur Sahin (Mainz, Germany), Mathias Vormehr (Mainz, Germany), Lena Mareen Kranz (Mainz, Germany), Sina Fellermeier-Kopf (Mainz, Germany), Alexander Muik (Mainz, Germany), Friederike Gieseke (Mainz, Germany), Bodo Tillmann (Frankfurt, Germany) and Sonja Witzel (Bad Vilbel, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to variants of interleukin-2 (IL2). In one embodiment, the IL2 vari...